TOP NEWS: AstraZeneca closes CinCor buy; Enhertu wins Chinese approval
(Alliance News) - AstraZeneca PLC on Friday reported that it completed the acquisition of CinCor Pharma Inc, which focuses on hypertension and chronic kidney disease, while its cancer drug Enhertu won another approval, its first in China. Read More